au.\*:("MALEJKA GIGANTI D")
Results 1 to 24 of 24
Selection :
A NOVEL ASSAY OF GLUCURONIDATION OF C- AND N-HYDROXYLATED METABOLITES OF THE CARCINOGEN N-2-FLUORENYLACETAMIDERYZEWSKI CN; MALEJKA GIGANTI D.1983; ANALYTICAL BIOCHEMISTRY; ISSN 0003-2697; USA; DA. 1983; VOL. 130; NO 2; PP. 420-426; BIBL. 28 REF.Article
LACK OF SUSCEPTIBILITY OF F344 RATS TO MAMMARY TUMOR INDUCTION BY TOPICALLY APPLIED FLUORENYLACETOHYDROXAMIC ACIDS AND THEIR ACETATES.MALEJKA GIGANTI D; RYDELL RE.1978; J. NATION. CANCER INST.; U.S.A.; DA. 1978; VOL. 60; NO 2; PP. 433-435; BIBL. 25 REF.Article
MIXED FUNCTION OXIDASE IN THE MAMMARY GLAND AND LIVER MICROSOMES OF LACTATING RATS: EFFECTS OF 3-METHYLCHOLANTHRENE AND BETA -NAPHTHOFLAVONERITTER CL; MALEJKA GIGANTI D.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 2; PP. 239-247; BIBL. 33 REF.Article
EFFECTS OF ACUTE OR CHRONIC TREATMENT OF RATS WITH N-2-FLUORENYL-ACETAMIDE ON ITS N-HYDROXYLATION AND ON HEMOPROTEINS OF HEPATIC MICROSOMESMALEJKA GIGANTI D; RITTER CL.1980; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1980; VOL. 28; NO 1; PP. 53-64; BIBL. 17 REF.Article
NH-HYDROXY-2-FLUORENYLACETAMIDE, AN ACTIVE INTERMEDIATE OF THE MAMMARY CARCINOGEN N-HYDROXY-2-FLUORENYLBENZENESULFONAMIDE. = LE N-HYDROXY-FLUORENYL-2 ACETAMIDE, UN INTERMEDIAIRE ACTIF DU CANCERIGENE MAMMAIRE, LE N-HYDROXY-FLUORENYL-2 BENZENESULFONAMIDEMALEJKA GIGANTI D; GUTMANN HR.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 150; NO 1; PP. 92-97; BIBL. 13 REF.Article
MAMMARY CARCINOGENESIS IN THE RAT BY TOPICAL APPLICATION OF FLUORENYLHYDROXAMIC ACIDS AND THEIR ACETATES.MALEJKA GIGANTI D; RYDELL RE; GUTMANN HR et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 1; PP. 111-117; BIBL. 46 REF.Article
ON THE CORRELATION BETWEEN THE HEPATOCARCINOGENICITY OF THE CARCINOGEN, N-2-FLUORENYLACETAMIDE, AND ITS METABOLIC ACTIVATION BY THE RAT = CORRELATION ENTRE L'HEPATOCANCERIGENICITE DU CANCERIGENE, N-2 FLUORENYLACETAMIDE ET SON ACTIVATION METABOLIQUE PAR LE RATGUTMANN HR; MALEJKA GIGANTI D; BARRY EJ et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 7; PP. 1554-1561; BIBL. 1P.Serial Issue
INDUCTION OF MICROSOMAL N-HYDROXYLATION OF N-2-FLUORENYLACETAMIDE IN RAT LIVER.MALEJKA GIGANTI D; MCIVER RC; GLASEBROOK AL et al.1978; BIOCHEM. PHARMACOL.; G.B.; DA. 1978; VOL. 27; NO 1; PP. 61-69; BIBL. 36 REF.Article
Microsomal metabolism of the carcinogen, N-2 fluorenyl-acetamide, by the mammary gland and liver of female rats. II: Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamideMALEJKA-GIGANTI, D; RYZEWSKI, C. N.Carcinogenesis (New York. Print). 1985, Vol 6, Num 5, pp 687-692, issn 0143-3334Article
STUDIES ON THE TRANSFORMATION OF RAT EMBRYO CELLS OF LOW PASSAGE BY CARCINOGENIC FLUORENYLHYDROXAMIC ACIDS AND THEIR ACETATE ESTERS.KURZEPA H; GUTMANN HR; MALEJKA GIGANTI D et al.1978; IN VITRO; USA; DA. 1978; VOL. 14; NO 3; PP. 261-270; BIBL. 1 P. 1/2Article
Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Effect of ovariectomyRITTER, C. L; MALEJKA-GIGANTI, D.Biochemical pharmacology. 1995, Vol 50, Num 8, pp 1265-1272, issn 0006-2952Article
Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamineMALEJKA-GIGANTI, D; MAGAT, W. J; DECKER, R. W et al.Xenobiotica (London. Print). 1989, Vol 19, Num 4, pp 431-444, issn 0049-8254Article
Cytochrome c/H2O2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals = Oxydation d'un électron médiée par le cytochrome c/H2O2 des acides N-fluorénylacétohydroxamiques carcinogènes en radicaux libres nitroxylRITTER, C. L; MALEJKA-GIGANTI, D; POLNASZEK, C. F et al.Chemico-biological interactions. 1983, Vol 46, Num 3, pp 317-334, issn 0009-2797Article
Determination of peroxidative halogenation in mixtures of chloride and bromideRITTER, C. L; STEAD, T. M; MALEJKA-GIGANTI, D et al.Analytical biochemistry. 1988, Vol 174, Num 1, pp 65-72, issn 0003-2697, 8 p.Article
Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide by rat peritoneal neutrophilsMALEJKA-GIGANTI, D; RITTER, C. L; WILLMOTT, L. D et al.Carcinogenesis (New York. Print). 1993, Vol 14, Num 3, pp 341-346, issn 0143-3334Article
Activation of the carcinogen N-hydroxy-N-(2-fluorenyl)benzamide via chemical and enzymatic oxidations. Comparison to oxidations of the structural analogue N-hydroxy-N-(2-fluorenyl)acetamideMALEJKA-GIGANTI, D; RITTER, C. L; DECKER, R. W et al.Chemical research in toxicology. 1992, Vol 5, Num 4, pp 520-527, issn 0893-228XArticle
Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or β-naphthoflavone administered to lactating rats = Modifications du métabolisme des carcinogènes dans les microsomes hépatiques de jeunes à la mamelle par le 3-méthyl-cholanthrène ou la bêta-naphtoflavine administrés à des rattes en période de lactationMALEJKA-GIGANTI, D; DECKER, R. W; RITTER, C. L et al.Biochemical pharmacology. 1983, Vol 32, Num 22, pp 3335-3344, issn 0006-2952Article
Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamideMALEJKA-GIGANTI, D; MAGAT, W. J; ADELMANN, A. M et al.Drug metabolism and disposition. 1987, Vol 15, Num 6, pp 760-766, issn 0090-9556Article
Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolitesMALEJKA-GIGANTI, D; RINGER, D. P; VIJAYARAGHAVAN, P et al.Experimental and molecular pathology. 1997, Vol 64, Num 2, pp 63-77, issn 0014-4800Article
Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitroMALEJKA-GIGANTI, D; RITTER, C. L; DECKER, R. W et al.Cancer research (Baltimore). 1986, Vol 46, Num 12, pp 6200-6206, issn 0008-5472, 1Article
Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I: Ring- and N-hydroxylations of N-2-fluorenylacetamideMALEJKA-GIGANTI, D; DECKER, R. W; RITTER, C. L et al.Carcinogenesis (New York. Print). 1985, Vol 6, Num 1, pp 95-103, issn 0143-3334Article
Detection of N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of peritoneal serosa and liver intraperitoneal exposure of rats to N-hydroxy-N-2-fluorenylbenzamide or N-hydroxy-N-2-fluorenylacetamideMALEJKA-GIGANTI, D; RITTER, C. L; FULLERTON, N. F et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 12, pp 2883-2890, issn 0143-3334Article
Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liverRITTER, C. L; BENNNETT, K. K; FULLERTON, N. F et al.Carcinogenesis (New York. Print). 1996, Vol 17, Num 11, pp 2411-2418, issn 0143-3334Article
